Chapter 16. Recent Advances in Anti-retroviral Chemotherapy for AIDS
- 1 January 1990
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesNature, 1990
- NMR investigation on the structure and conformation of 3′-azido-2′,3′-dideoxyribosylthymine (AZT), an inhibitor of the HIV (AIDS virus)Biochemical and Biophysical Research Communications, 1989
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Antiviral Therapy in Human Immunodeficiency Virus InfectionDrugs, 1989
- Stable Indicator Cell Lines Exhibiting HIV-1tatFunctionAIDS Research and Human Retroviruses, 1989
- Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerasesBiochemical and Biophysical Research Communications, 1989
- Involvement of tryptase‐related cellular protease(s) in human immunodeficiency virus type 1 infectionFEBS Letters, 1989
- Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin AFEBS Letters, 1989
- Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinasesFEBS Letters, 1989
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsBiochemical and Biophysical Research Communications, 1988